Home
About Us
News
R&D
Manufacture
Products
Culture
Qingfeng Pharmaceutical Group
中文
English
News
Qingfeng Pharmaceutical Group Lenvatinib Mesylate capsule was approved for listing
Qingfeng was listed as the "best industrial enterprise in China's pharmaceutical R & D product line"
Qingfeng Pharma. new method for synthesizing lacosamide won the Chinese patent Excellence Award
Qingfeng won the bid for the fourth batch of national volume based procurement for two products
Xinkang® Lacosamide injection was approved by NMPA